Merck & Co., Inc.
MRK
$75.97
-$1.68-2.16%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.66% | 405.30% | -33.47% | 191.30% | 68.81% |
| Total Depreciation and Amortization | 15.13% | 23.37% | 17.18% | 21.00% | -5.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.52% | 5.41% | 1,414.75% | -98.77% | 80.59% |
| Change in Net Operating Assets | -9.76% | -1,388.19% | 18.60% | 38.14% | -17.02% |
| Cash from Operations | -19.09% | 1,302.44% | 20.40% | 52.19% | 130.77% |
| Capital Expenditure | -54.24% | 5.26% | 13.19% | 18.03% | 14.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 43.78% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -168.83% | -148.46% | -50.18% | -222.47% | 1,024.00% |
| Cash from Investing | -8.07% | -2,824.53% | -1,051.20% | 90.66% | 41.67% |
| Total Debt Issued | -- | -- | 99.95% | -54.33% | -- |
| Total Debt Repaid | -232.89% | -17,866.67% | 100.00% | 100.00% | -75,000.00% |
| Issuance of Common Stock | -78.16% | 100.00% | -28.57% | -10.98% | 190.00% |
| Repurchase of Common Stock | -854.10% | -24.43% | 4.72% | 25.74% | 18.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.13% | -5.35% | -5.28% | -5.36% | -5.23% |
| Other Financing Activities | 23.08% | -1,300.00% | -220.00% | 5.98% | 3.70% |
| Cash from Financing | -104.51% | -34.03% | 43.20% | -67.64% | -37.00% |
| Foreign Exchange rate Adjustments | 213.04% | -297.31% | 287.26% | 11.83% | -258.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -270.44% | 22.16% | 12.11% | 239.96% | 58.55% |